Name: Bifidobacterium breve S1
Creator: BacDive
License: http://creativecommons.org/licenses/by-nc/4.0/

Strain identifier

BacDive ID: 1695

Type strain:

Species: Bifidobacterium breve

Strain Designation: S1

Culture col. no.: DSM 20213, ATCC 15700, NCTC 11815, JCM 1192, BCRC 11846, CCUG 18365, CCUG 30511, CECT 4839, CGMCC 1.2213, CIP 64.69, KCTC 3220, LMG 10501, LMG 11042, NCFB 2257, NCDO 2257, WDCM 00224

Strain history: CIP <- 1964, Lab. Ident. Inst. Pasteur, Paris, France <- M. Sebald, Inst. Pasteur, Paris, France <- H. Werner <- G. Reuter: strain S1

NCBI tax ID(s): 518634 (strain), 1685 (species)

SI-ID 92168

LMG 11042, ATCC 15700, CCRC 11846, CCUG 18365, CCUG 30511, DSM 20213, JCM 1192, LMG 10501, NCFB 2257, NCTC 11815, LMG 13208, NCDO 2257, NCIMB 702257, CECT 4839, KCTC 3220, AS 1.2213, CCUG 30511 A, BCRC 11846, HAMBI 558, NCAIM B.01820, NRRL B-41408, CGMCC 1.2213, VTT E-981075, CIP 64.69

Other strains from Bifidobacterium breve

B. breve S50 (Variant a), S50, DSM 20091, ...
B. breve 17c, CIP 64.68, ATCC 15699, CCUG ...
B. breve S46, CIP 64.70, ATCC 15701, JCM ...
B. breve 755-84, CIP 101158
B. breve CCUG 5862, NCTC 10471
B. breve CCUG 16568
B. breve CCUG 16569
B. breve CCUG 27171 A
B. breve CCUG 30785
B. breve CCUG 32526 B
B. breve CCUG 33558
B. breve CCUG 34405
B. breve CCUG 35244
B. breve CCUG 35245
B. breve CCUG 42620
B. breve CCUG 42657
B. breve CCUG 43395 A
B. breve CCUG 43395 B
B. breve CCUG 44623
B. breve CCUG 46983
B. breve CCUG 47591
B. breve CCUG 47672
B. breve CCUG 47820
B. breve CCUG 47844
B. breve CCUG 51291
B. breve CCUG 53196
B. breve CCUG 53338
B. breve CCUG 55738
B. breve CCUG 55883
B. breve CCUG 59045
B. breve CCUG 59290
B. breve JCM 7017
B. breve JCM 7019
B. breve JCM 7020

Section

Bifidobacterium breve S1 is an anaerobe, mesophilic human pathogen that was isolated from intestine of infant.

anaerobe
human pathogen
mesophilic
16S sequence
Bacteria
genome sequence

Information on the name and the taxonomic classification. Name and taxonomic classification

	Last LPSN update	14-12-2023 (DD-MM-YYYY)
	Domain	"Bacteria"
	Phylum	*Actinomycetota*
	Class	*Actinomycetes*
	Order	*Bifidobacteriales*
	Family	*Bifidobacteriaceae*
	Genus	*Bifidobacterium*
	Species	**Bifidobacterium breve**
	Full Scientific Name (LPSN)	Bifidobacterium breve Reuter 1963 (Approved Lists 1980)

Information on morphological and physiological properties Morphology

[Ref.: #117003]	Gram stain	positive
[Ref.: #69480]	Gram stain	positive Confidence in %100

[Ref.: #117003]	Cell shape	rod-shaped

[Ref.: #117003]	Motility	no
[Ref.: #69480]	Motility	no Confidence in %92.212

Information on culture and growth conditions Culture and growth conditions

[Ref.: #8482]

Culture medium

BIFIDOBACTERIUM MEDIUM (DSMZ Medium 58)

[Ref.: #8482]

Culture medium growth

[Ref.: #8482]

Culture medium link

Medium recipe at MediaDive

[Ref.: #8482]

Culture medium composition

expand / minimize

[Ref.: #42088]

Culture medium

MEDIUM 20 - for Anaerobic bacteria

[Ref.: #42088]

Culture medium growth

[Ref.: #42088]

Culture medium composition

expand / minimize

[Ref.: #117003]

Culture medium

CIP Medium 20

[Ref.: #117003]

Culture medium growth

[Ref.: #117003]

Culture medium link

Medium recipe provided by DSMZ

		Temperature
[Ref.: #8482]	growth	37 °C
[Ref.: #42088]	growth	37 °C
[Ref.: #67770]	growth	37 °C

[Ref.: #8482]	Temperature range	mesophilic
[Ref.: #42088]	Temperature range	mesophilic
[Ref.: #67770]	Temperature range	mesophilic

Information on physiology and metabolism Physiology and metabolism

[Ref.: #8482]	Oxygen tolerance	anaerobe
[Ref.: #69480]	Oxygen tolerance	anaerobe Confidence in %99.423

[Ref.: #69481]	Ability of spore formation	no Confidence in %100
[Ref.: #69480]	Ability of spore formation	no Confidence in %99.986

[Ref.: #8482]	Murein short key	A11.01
[Ref.: #8482]	Murein types	A3alpha L-Lys-Gly

	Metabolite	Utilization activity	Kind of utilization tested
[Ref.: #68371]	cellobiose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-arabitol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-fructose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-fucose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-galactose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-glucose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-lyxose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-mannitol ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-ribose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-sorbitol ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-tagatose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-xylose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	erythritol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #117003]	esculin ChEBI	+	hydrolysis
[Ref.: #68371]	esculin ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	galactitol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	gluconate ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	glycerol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	glycogen ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	inulin ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-arabinose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-arabitol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-rhamnose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-sorbose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-xylose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	lactose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	maltose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	melezitose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	melibiose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	methyl alpha-D-glucopyranoside ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	methyl alpha-D-mannoside ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	methyl beta-D-xylopyranoside ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	myo-inositol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	N-acetylglucosamine ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #117003]	nitrate ChEBI	-	reduction
[Ref.: #117003]	nitrite ChEBI	-	reduction
[Ref.: #68371]	Potassium 2-ketogluconate ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	Potassium 5-ketogluconate ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	raffinose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	ribitol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	salicin ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	sucrose ChEBI	+	builds acid from	* from API 50CH acid
[Ref.: #68371]	trehalose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	turanose ChEBI	+	builds acid from	* from API 50CH acid
	Only first 10 entries are displayed. Click here to see all.

	Antibiotica	Metabolite	Antibiotic sensitivity	Antibiotic resistance
[Ref.: #117003]		metronidazole ChEBI	no	yes

	Metabolite production	Metabolite	Production
[Ref.: #117003]		indole ChEBI	no

	Enzyme	Enzyme activity	EC number
[Ref.: #68382]	acid phosphatase	+	3.1.3.2	* from API zym
[Ref.: #68382]	alkaline phosphatase	-	3.1.3.1	* from API zym
[Ref.: #68382]	alpha-chymotrypsin	-	3.4.21.1	* from API zym
[Ref.: #68382]	alpha-fucosidase	-	3.2.1.51	* from API zym
[Ref.: #68382]	alpha-galactosidase	+	3.2.1.22	* from API zym
[Ref.: #68382]	alpha-glucosidase	+	3.2.1.20	* from API zym
[Ref.: #68382]	alpha-mannosidase	-	3.2.1.24	* from API zym
[Ref.: #117003]	amylase	-
[Ref.: #117003]	beta-galactosidase	+	3.2.1.23
[Ref.: #68382]	beta-galactosidase	+	3.2.1.23	* from API zym
[Ref.: #68382]	beta-glucosidase	+	3.2.1.21	* from API zym
[Ref.: #68382]	beta-glucuronidase	-	3.2.1.31	* from API zym
[Ref.: #117003]	caseinase	+	3.4.21.50
[Ref.: #117003]	catalase	-	1.11.1.6
[Ref.: #68382]	cystine arylamidase	-	3.4.11.3	* from API zym
[Ref.: #117003]	DNase	-
[Ref.: #68382]	esterase (C 4)	+		* from API zym
[Ref.: #68382]	esterase lipase (C 8)	-		* from API zym
[Ref.: #117003]	gelatinase	-
[Ref.: #117003]	lecithinase	-
[Ref.: #68382]	leucine arylamidase	+	3.4.11.1	* from API zym
[Ref.: #117003]	lipase	-
[Ref.: #68382]	lipase (C 14)	-		* from API zym
[Ref.: #68382]	N-acetyl-beta-glucosaminidase	+	3.2.1.52	* from API zym
[Ref.: #68382]	naphthol-AS-BI-phosphohydrolase	-		* from API zym
[Ref.: #117003]	oxidase	-
[Ref.: #117003]	protease	-
[Ref.: #68382]	trypsin	-	3.4.21.4	* from API zym
[Ref.: #117003]	tween esterase	-
[Ref.: #117003]	urease	-	3.5.1.5
[Ref.: #68382]	valine arylamidase	-		* from API zym
	Only first 10 entries are displayed. Click here to see all.

API® 50CH acid:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	ControlQ	Acid from glycerolGLY	Acid from erythritolERY	Acid from D-arabinoseDARA	Acid from L-arabinoseLARA	Acid from D-riboseRIB	Acid from D-xyloseDXYL	Acid from L-xyloseLXYL	Acid from D-adonitolADO	Acid from methyl beta-D-xylopyranosideMDX	Acid from D-galactoseGAL	Acid from D-glucoseGLU	Acid from D-fructoseFRU	Acid from D-mannoseMNE	Acid from L-sorboseSBE	Acid from L-rhamnoseRHA	Acid from dulcitolDUL	Acid from inositolINO	Acid from D-mannitolMAN	Acid from D-sorbitolSOR	Acid from methyl alpha-D-mannopyranosideMDM	Acid from methyl alpha-D-glucopyranosideMDG	Acid from N-acetyl-glucosamineNAG	Acid from amygdalinAMY	Acid from arbutinARB	Acid from esculinESC	Acid from salicinSAL	Acid from cellobioseCEL	Acid from maltoseMAL	Acid from lactoseLAC	Acid from melibioseMEL	Acid from sucroseSAC	Acid from trehaloseTRE	Acid from inulinINU	Acid from melezitoseMLZ	Acid from raffinoseRAF	Acid from starchAMD	Acid from glycogenGLYG	Acid from xylitolXLT	Acid from gentiobioseGEN	Acid from turanoseTUR	Acid from D-lyxoseLYX	Acid from D-tagatoseTAG	Acid from D-fucoseDFUC	Acid from L-fucoseLFUC	Acid from D-arabitolDARL	Acid from L-arabitolLARL	Acid from gluconateGNT	Acid from 2-Ketogluconate2KG	Acid from 5-Ketogluconate5KG
[Ref.: #8482]	14575	-	-	-	+	-	+	-	-	-	-	+	+	+	+	-	-	-	-	+	+	-	+	+	+	+	+	+	+	+	+	+	+	-	-	-	+	-	+	-	-	+	-	-	-	+	-	-	-	-	-
[Ref.: #8482]	14574	-	-	-	-	-	+	-	-	-	-	+	+	+	-	-	-	-	-	+	+	-	+	+	+	+	+	+	+	+	+	+	+	-	-	-	+	-	+	-	-	+	-	-	-	+	-	-	-	-	-
[Ref.: #8482]	14573	-	-	-	+	-	+	-	-	-	-	+	+	+	+	-	-	-	-	+	+	-	+	+	+	+	+	+	+	+	+	+	+	-	-	-	+	+/-	+	+/-	+	+	-	-	-	+	-	-	-	-	-
[Ref.: #8482]	14572	-	-	-	+	-	+	-	-	-	-	+	+	+	+	-	-	-	-	+	+	-	+	+	+	+	+	+	+	+	+	+	+	-	-	-	+	+	+	+/-	+	+	-	-	-	+	-	-	-	-	-
[Ref.: #8482]	14571	-	-	-	+	-	+	-	-	-	-	+	+	+	+	-	-	-	-	+	+	-	+	+	+	+	+	+	+	+	+	+	+	-	-	-	+	+	+	+	+	+	-	-	-	+	-	-	-	-	-
[Ref.: #8482]	14570	-	-	-	-	-	+	-	-	-	-	+	+	+	+/-	-	-	-	-	+	+	-	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	-	+	-	-	+	-	-	-	+/-	-	-	-	-	-

API® zym:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Control	2-naphthyl phosphateAlkaline phosphatase	2-naphthyl butyrateEsterase (C 4)	2-naphtyl caprylateEsterase Lipase (C 8)	2-naphthyl myristateLipase (C 14)	L-leucyl-2-naphthylamideLeucine arylamidase	L-valyl-2-naphthylamideValine arylamidase	L-cystyl-2-naphthylamideCystine arylamidase	N-benzoyl-DL-arginine-2-naphthylamideTrypsin	N-glutaryl-phenylalanine-2-naphthylamidealpha- Chymotrypsin	2-naphthyl phosphateAcid phosphatase	Naphthol-AS-BI-phosphateNaphthol-AS-BI-phosphohydrolase	6-Br-2-naphthyl-alphaD-galactpyranosidealpha- Galactosidase	2-naphthyl-betaD-galactpyranosidebeta- Galactosidase	Naphthol-AS-BI-betaD-glucuronidebeta- Glucuronidase	2-naphthyl-alphaD-glucopyranosidealpha- Glucosidase	6-Br-2-naphthyl-betaD-glucopyranosidebeta- Glucosidase	1-naphthyl-N-acetyl-betaD-glucosaminideN-acetyl-beta- glucosaminidase	6-Br-2-naphthyl-alphaD-mannopyranosidealpha- Mannosidase	2-naphthyl-alphaL-fucopyranosidealpha- Fucosidase
[Ref.: #117003]	13067	-	-	+	-	-	+	-	-	-	-	+	-	+	+	-	+	+	+	-	-

	Pathway	Enzyme coverage	Annotated reactions
	Pathway annotation	Computationally determined by
[Ref.: #66794]	ppGpp biosynthesis	100	4 of 4
[Ref.: #66794]	CDP-diacylglycerol biosynthesis	100	2 of 2
[Ref.: #66794]	UDP-GlcNAc biosynthesis	100	3 of 3
[Ref.: #66794]	adipate degradation	100	2 of 2
[Ref.: #66794]	vitamin B1 metabolism	100	13 of 13
[Ref.: #66794]	anapleurotic synthesis of oxalacetate	100	1 of 1
[Ref.: #66794]	folate polyglutamylation	100	1 of 1
[Ref.: #66794]	starch degradation	100	10 of 10
[Ref.: #66794]	acetoin degradation	100	3 of 3
[Ref.: #66794]	L-lactaldehyde degradation	100	3 of 3
[Ref.: #66794]	pentose phosphate pathway	90.91	10 of 11
[Ref.: #66794]	threonine metabolism	90	9 of 10
[Ref.: #66794]	chorismate metabolism	88.89	8 of 9
[Ref.: #66794]	peptidoglycan biosynthesis	86.67	13 of 15
[Ref.: #66794]	palmitate biosynthesis	86.36	19 of 22
[Ref.: #66794]	photosynthesis	85.71	12 of 14
[Ref.: #66794]	glycogen metabolism	80	4 of 5
[Ref.: #66794]	valine metabolism	77.78	7 of 9
[Ref.: #66794]	NAD metabolism	77.78	14 of 18
[Ref.: #66794]	sulfopterin metabolism	75	3 of 4
[Ref.: #66794]	acetate fermentation	75	3 of 4
[Ref.: #66794]	C4 and CAM-carbon fixation	75	6 of 8
[Ref.: #66794]	glycogen biosynthesis	75	3 of 4
[Ref.: #66794]	cardiolipin biosynthesis	71.43	5 of 7
[Ref.: #66794]	Entner Doudoroff pathway	70	7 of 10
[Ref.: #66794]	phenylalanine metabolism	69.23	9 of 13
[Ref.: #66794]	degradation of sugar alcohols	68.75	11 of 16
[Ref.: #66794]	glycolate and glyoxylate degradation	66.67	4 of 6
[Ref.: #66794]	formaldehyde oxidation	66.67	2 of 3
[Ref.: #66794]	aspartate and asparagine metabolism	66.67	6 of 9
[Ref.: #66794]	IAA biosynthesis	66.67	2 of 3
[Ref.: #66794]	serine metabolism	66.67	6 of 9
[Ref.: #66794]	CO2 fixation in Crenarchaeota	66.67	6 of 9
[Ref.: #66794]	tetrahydrofolate metabolism	64.29	9 of 14
[Ref.: #66794]	purine metabolism	62.77	59 of 94
[Ref.: #66794]	gluconeogenesis	62.5	5 of 8
[Ref.: #66794]	isoleucine metabolism	62.5	5 of 8
[Ref.: #66794]	6-hydroxymethyl-dihydropterin diphosphate biosynthesis	62.5	5 of 8
[Ref.: #66794]	methionine metabolism	61.54	16 of 26
[Ref.: #66794]	glutamate and glutamine metabolism	60.71	17 of 28
[Ref.: #66794]	lipoate biosynthesis	60	3 of 5
[Ref.: #66794]	pyrimidine metabolism	60	27 of 45
[Ref.: #66794]	metabolism of amino sugars and derivatives	60	3 of 5
[Ref.: #66794]	oxidative phosphorylation	59.34	54 of 91
[Ref.: #66794]	glycolysis	58.82	10 of 17
[Ref.: #66794]	d-mannose degradation	55.56	5 of 9
[Ref.: #66794]	histidine metabolism	55.17	16 of 29
[Ref.: #66794]	alanine metabolism	55.17	16 of 29
[Ref.: #66794]	vitamin B6 metabolism	54.55	6 of 11
[Ref.: #66794]	d-xylose degradation	54.55	6 of 11
[Ref.: #66794]	metabolism of disaccharids	54.55	6 of 11
[Ref.: #66794]	leucine metabolism	53.85	7 of 13
[Ref.: #66794]	isoprenoid biosynthesis	53.85	14 of 26
[Ref.: #66794]	dTDPLrhamnose biosynthesis	50	4 of 8
[Ref.: #66794]	ribulose monophosphate pathway	50	1 of 2
[Ref.: #66794]	ethanol fermentation	50	1 of 2
[Ref.: #66794]	mannosylglycerate biosynthesis	50	1 of 2
[Ref.: #66794]	cis-vaccenate biosynthesis	50	1 of 2
[Ref.: #66794]	tryptophan metabolism	50	19 of 38
[Ref.: #66794]	coenzyme A metabolism	50	2 of 4
[Ref.: #66794]	butanoate fermentation	50	2 of 4
[Ref.: #66794]	cysteine metabolism	50	9 of 18
[Ref.: #66794]	ketogluconate metabolism	50	4 of 8
[Ref.: #66794]	phenylmercury acetate degradation	50	1 of 2
[Ref.: #66794]	citric acid cycle	50	7 of 14
[Ref.: #66794]	degradation of pentoses	46.43	13 of 28
[Ref.: #66794]	proline metabolism	45.45	5 of 11
[Ref.: #66794]	lipid metabolism	45.16	14 of 31
[Ref.: #66794]	non-pathway related	44.74	17 of 38
[Ref.: #66794]	degradation of hexoses	44.44	8 of 18
[Ref.: #66794]	propanol degradation	42.86	3 of 7
[Ref.: #66794]	reductive acetyl coenzyme A pathway	42.86	3 of 7
[Ref.: #66794]	tyrosine metabolism	42.86	6 of 14
[Ref.: #66794]	glutathione metabolism	42.86	6 of 14
[Ref.: #66794]	arginine metabolism	41.67	10 of 24
[Ref.: #66794]	lysine metabolism	40.48	17 of 42
[Ref.: #66794]	cellulose degradation	40	2 of 5
[Ref.: #66794]	vitamin K metabolism	40	2 of 5
[Ref.: #66794]	methylglyoxal degradation	40	2 of 5
[Ref.: #66794]	lipid A biosynthesis	33.33	3 of 9
[Ref.: #66794]	octane oxidation	33.33	1 of 3
[Ref.: #66794]	4-hydroxymandelate degradation	33.33	3 of 9
[Ref.: #66794]	acetyl CoA biosynthesis	33.33	1 of 3
[Ref.: #66794]	flavin biosynthesis	33.33	5 of 15
[Ref.: #66794]	sulfoquinovose degradation	33.33	1 of 3
[Ref.: #66794]	selenocysteine biosynthesis	33.33	2 of 6
[Ref.: #66794]	degradation of aromatic, nitrogen containing compounds	33.33	4 of 12
[Ref.: #66794]	molybdenum cofactor biosynthesis	33.33	3 of 9
[Ref.: #66794]	cyanate degradation	33.33	1 of 3
[Ref.: #66794]	degradation of sugar acids	32	8 of 25
[Ref.: #66794]	urea cycle	30.77	4 of 13
[Ref.: #66794]	glycine metabolism	30	3 of 10
[Ref.: #66794]	propionate fermentation	30	3 of 10
[Ref.: #66794]	benzoyl-CoA degradation	28.57	2 of 7
[Ref.: #66794]	CMP-KDO biosynthesis	25	1 of 4
[Ref.: #66794]	lactate fermentation	25	1 of 4
[Ref.: #66794]	carnitine metabolism	25	2 of 8
[Ref.: #66794]	cyclohexanol degradation	25	1 of 4
[Ref.: #66794]	sulfate reduction	23.08	3 of 13
[Ref.: #66794]	nitrate assimilation	22.22	2 of 9
[Ref.: #66794]	allantoin degradation	22.22	2 of 9
		Only first 10 entries are displayed. Click here to see all.

Information on isolation source, the sampling and environmental conditions Isolation, sampling and environmental information

[Ref.: #8482]	Sample type/isolated from	intestine of infant

[Ref.: #67770]	Sample type/isolated from	Intestine of infant

[Ref.: #117003]	Sample type/isolated from	Human, Infant, intestine
* marker position based on {}

Isolation sources categories

#Host	#Human	#Child
#Host Body-Site	#Gastrointestinal tract	-

What are isolation sources categories?

[Ref.: #69479]

Global distribution of 16S sequence LC071793 (>99% sequence identity) for Bifidobacterium breve subclade from Microbeatlas

Aquatic Samples	3177
Soil Samples	1133
Animal Samples	142996
Plant Samples	360
Total Samples	147666

Information on possible application of the strain and its possible interaction with e.g. potential hosts Safety information

[Ref.: #8482]	Pathogenicity (human)	yes, in single cases
[Ref.: #8482]	Biosafety level	1	Risk group (German classification) According to TRBA 466
[Ref.: #117003]	Biosafety level	1	Risk group (French classification)

Information on genomic background e.g. entries in nucleic sequence databass Sequence information

16S Sequence information:

Only first 5 entries are displayed. Click here to see all.

	Sequence accession description	Seq. accession number	Sequence length (bp)	Sequence database	Associated NCBI tax ID
[Ref.: #67770]	Bifidobacterium breve gene for 16S ribosomal RNA, partial sequence, strain: JCM 1192	LC071793	1418	ENA	518634 tax ID
[Ref.: #20218]	Bifidobacterium breve gene for 16S rRNA, partial sequence, strain: ATCC 15700	AB006658	1520	ENA	518634 tax ID	*
[Ref.: #20218]	Bifidobacterium breve partial 16S rRNA gene, type strain ATCC 15700T	AM411121	179	ENA	518634 tax ID	*
[Ref.: #20218]	Bifidobacterium breve 16S ribosomal RNA	M58731	1536	ENA	1685 tax ID	*
[Ref.: #20218]	Bifodibacterium breve (ATCC 15700) 16S ribosomal RNA gene, partial	M84776	642	ENA	1685 tax ID	*
[Ref.: #20218]	Bifidobacterium breve strain DSM 20213 16S ribosomal RNA gene, partial sequence	HQ012023	939	ENA	518634 tax ID	*
[Ref.: #20218]	Bifidobacterium breve gene for 16S rRNA, partial sequence, strain: JCM 1192	AB116288	479	ENA	518634 tax ID	*
[Ref.: #20218]	Bifidobacterium breve gene for 16S rRNA, partial sequence, strain: JCM 1192	AB507084	672	ENA	518634 tax ID	*
[Ref.: #20218]	Bifidobacterium breve strain KCTC 3220 16S ribosomal RNA gene, partial sequence	GU361815	1483	ENA	1685 tax ID	*

Genome sequence information:

Only first 5 entries are displayed. Click here to see all.

	Sequence accession description	Seq. accession number	Assembly level	Sequence database	Associated NCBI tax ID
[Ref.: #67770]	Bifidobacterium breve DSM 20213 = JCM 1192	GCA_000158015	scaffold	GenBank	518634 tax ID
[Ref.: #67770]	Bifidobacterium breve DSM 20213 = JCM 1192 DNA, complete genome	AP012324		GenBank	518634 tax ID
[Ref.: #67770]	Bifidobacterium breve DSM 20213 = JCM 1192	GCA_001311295	contig	GenBank	518634 tax ID
[Ref.: #67770]	Bifidobacterium breve DSM 20213 = JCM 1192	GCA_000771305	contig	GenBank	518634 tax ID
[Ref.: #66792]	Bifidobacterium breve DSM 20213 = JCM 1192	518634.7	wgs	PATRIC	518634 tax ID	*
[Ref.: #66792]	Bifidobacterium breve DSM 20213 = JCM 1192	518634.19	wgs	PATRIC	518634 tax ID	*

[Ref.: #8482]	GC-content	58.4 mol%
[Ref.: #67770]	GC-content	58.4 mol%	thermal denaturation, midpoint method (Tm)

Data predicted using genome information as a basis Genome-based predictions

	Trait	Prediction	Confidence in %	In training data
	Predictions from GenomeNet Sporulation v. 1 based on: Bifidobacterium breve DSM 20213 = JCM 1192 JCM 1192 NCBI: GCA_001025175.1
[Ref.: #69481]	spore-forming	no	100	no

	Trait	Prediction	Confidence in %	In training data
	Predictions from Diaspora project based on: Bifidobacterium breve DSM 20213 = JCM 1192 JCM 1192 NCBI: GCA_001025175.1
[Ref.: #69480]	motile	no	93.984	no
[Ref.: #69480]	flagellated	no	96.349	no
[Ref.: #69480]	gram-positive	yes	94.216	no
[Ref.: #69480]	anaerobic	yes	97.636	no
[Ref.: #69480]	aerobic	no	95.691	yes
[Ref.: #69480]	halophile	no	74.392	no
[Ref.: #69480]	spore-forming	no	96.013	no
[Ref.: #69480]	thermophile	no	98.004	no
[Ref.: #69480]	glucose-util	yes	86.688	no
[Ref.: #69480]	glucose-ferment	yes	87.999	no

Availability in culture collections External links

[Ref.: #8482]

Culture collection no.

DSM 20213, ATCC 15700, NCTC 11815, JCM 1192, BCRC 11846, CCUG 18365, CCUG 30511, CECT 4839, CGMCC 1.2213, CIP 64.69, KCTC 3220, LMG 10501, LMG 11042, NCFB 2257, NCDO 2257, WDCM 00224

[Ref.: #71342]

SI-ID 92168

Literature:

Only first 10 entries are displayed. Click here to see all.

Topic	Title	Authors	Journal	DOI	Year
Phylogeny	Comparison of 16S rRNA Gene Based Microbial Profiling Using Five Next-Generation Sequencers and Various Primers.	Park C, Kim SB, Choi SH, Kim S	Front Microbiol	10.3389/fmicb.2021.715500	2021	*
Pathogenicity	Safety Evaluation of Bifidobacterium breve IDCC4401 Isolated from Infant Feces for Use as a Commercial Probiotic.	Choi IY, Kim J, Kim SH, Ban OH, Yang J, Park MK	J Microbiol Biotechnol	10.4014/jmb.2103.03041	2021	*
Biotechnology	Impact of prebiotics on equol production from soymilk isoflavones by two Bifidobacterium species.	Mustafa SE, Mustafa S, Ismail A, Abas F, Abd Manap MY, Ahmed Hamdi OA, Elzen S, Nahar L, Sarker SD	Heliyon	10.1016/j.heliyon.2020.e05298	2020	*
Metabolism	Linoleic acid induces metabolic stress in the intestinal microorganism Bifidobacterium breve DSM 20213.	Senizza A, Rocchetti G, Callegari ML, Lucini L, Morelli L	Sci Rep	10.1038/s41598-020-62897-w	2020	*
Enzymology	Highly Selective Production of Compound K from Ginsenoside Rd by Hydrolyzing Glucose at C-3 Glycoside Using beta-Glucosidase of Bifidobacterium breve ATCC 15700.	Zhang R, Huang XM, Yan HJ, Liu XY, Zhou Q, Luo ZY, Tan XN, Zhang BL	J Microbiol Biotechnol	10.4014/jmb.1808.08059	2019	*
Phylogeny	Bifidobacterium callitrichidarum sp. nov. from the faeces of the emperor tamarin (Saguinus imperator).	Modesto M, Michelini S, Sansosti MC, De Filippo C, Cavalieri D, Qvirist L, Andlid T, Spiezio C, Sandri C, Pascarelli S, Sgorbati B, Mattarelli P	Int J Syst Evol Microbiol	10.1099/ijsem.0.002472	2017	*
Metabolism	Human milk oligosaccharide consumption by probiotic and human-associated bifidobacteria and lactobacilli.	Thongaram T, Hoeflinger JL, Chow J, Miller MJ	J Dairy Sci	10.3168/jds.2017-12753	2017	*
Metabolism	Mechanistic Study of Utilization of Water-Insoluble Saccharomyces cerevisiae Glucans by Bifidobacterium breve Strain JCM1192.	Keung HY, Li TK, Sham LT, Cheung MK, Cheung PCK, Kwan HS	Appl Environ Microbiol	10.1128/AEM.03442-16	2017	*
Enzymology	In vitro and in vivo evaluation of the prebiotic effect of raw and roasted almonds (Prunus amygdalus).	Liu Z, Wang W, Huang G, Zhang W, Ni L	J Sci Food Agric	10.1002/jsfa.7604	2016	*
Pathogenicity	Interaction of mouse splenocytes and macrophages with bacterial strains in vitro: the effect of age in the immune response.	Van Beek AA, Hoogerland JA, Belzer C, De Vos P, De Vos WM, Savelkoul HF, Leenen PJ	Benef Microbes	10.3920/BM2015.0094	2015	*
Genetics	Complete genome sequence of Bifidobacterium breve JCM 1192(T) isolated from infant feces.	Morita H, Toh H, Oshima K, Nakano A, Omori E, Hattori Y, Arakawa K, Suda W, Honda K, Hattori M	J Biotechnol	10.1016/j.jbiotec.2015.06.414	2015	*
Pathogenicity	RNA of Enterococcus faecalis Strain EC-12 Is a Major Component Inducing Interleukin-12 Production from Human Monocytic Cells.	Nishibayashi R, Inoue R, Harada Y, Watanabe T, Makioka Y, Ushida K	PLoS One	10.1371/journal.pone.0129806	2015	*
Metabolism	Two beta-galactosidases from the human isolate Bifidobacterium breve DSM 20213: molecular cloning and expression, biochemical characterization and synthesis of galacto-oligosaccharides.	Arreola SL, Intanon M, Suljic J, Kittl R, Pham NH, Kosma P, Haltrich D, Nguyen TH	PLoS One	10.1371/journal.pone.0104056	2014	*
Phylogeny	Isolation of a bifidogenic peptide from the pepsin hydrolysate of bovine lactoferrin.	Oda H, Wakabayashi H, Yamauchi K, Sato T, Xiao JZ, Abe F, Iwatsuki K	Appl Environ Microbiol	10.1128/AEM.03343-12	2013	*
Pathogenicity	Identification and accurate quantitation of biological oligosaccharide mixtures.	Strum JS, Kim J, Wu S, De Leoz ML, Peacock K, Grimm R, German JB, Mills DA, Lebrilla CB	Anal Chem	10.1021/ac301128s	2012	*
Metabolism	Characterization of a Panela cheese with added probiotics and fava bean starch.	Escobar MC, Van Tassell ML, Martinez-Bustos F, Singh M, Castano-Tostado E, Amaya-Llano SL, Miller MJ	J Dairy Sci	10.3168/jds.2011-4655	2012	*
Metabolism	Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria.	Asakuma S, Hatakeyama E, Urashima T, Yoshida E, Katayama T, Yamamoto K, Kumagai H, Ashida H, Hirose J, Kitaoka M	J Biol Chem	10.1074/jbc.M111.248138	2011	*
Pathogenicity	The influence of some probiotic supernatants on the growth and virulence features expression of several selected enteroaggregative E. coli clinical strains.	Lazar V, Miyazaki Y, Hanawa T, Chifiriuc MC, Ditu LM, Marutescu L, Bleotu C, Kamiya S	Roum Arch Microbiol Immunol		2009	*
Metabolism	In vitro fermentation of arabinoxylan-derived carbohydrates by bifidobacteria and mixed fecal microbiota.	Pastell H, Westermann P, Meyer AS, Tuomainen P, Tenkanen M	J Agric Food Chem	10.1021/jf901397b	2009	*
Pathogenicity	Synbiotic promotion of epithelial proliferation by orally ingested encapsulated Bifidobacterium breve and raffinose in the small intestine of rats.	Ishizuka S, Iwama A, Dinoto A, Suksomcheep A, Maeta K, Kasai T, Hara H, Yokota A	Mol Nutr Food Res	10.1002/mnfr.200800041	2009	*
Pathogenicity	Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice.	Matsumoto T, Ishikawa H, Tateda K, Yaeshima T, Ishibashi N, Yamaguchi K	J Appl Microbiol	10.1111/j.1365-2672.2007.03593.x	2007	*
Pathogenicity	Yoghurt fermented by Lactobacillus delbrueckii subsp. bulgaricus H+ -ATPase-defective mutants exhibits enhanced viability of Bifidobacterium breve during storage.	Ongol MP, Sawatari Y, Ebina Y, Sone T, Tanaka M, Tomita F, Yokota A, Asano K	Int J Food Microbiol	10.1016/j.ijfoodmicro.2007.02.019	2007	*
Pathogenicity	Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria.	Kurdi P, Kawanishi K, Mizutani K, Yokota A	J Bacteriol	10.1128/JB.188.5.1979-1986.2006	2006	*
Phylogeny	Modulation of rat cecal microbiota by administration of raffinose and encapsulated Bifidobacterium breve.	Dinoto A, Suksomcheep A, Ishizuka S, Kimura H, Hanada S, Kamagata Y, Asano K, Tomita F, Yokota A	Appl Environ Microbiol	10.1128/AEM.72.1.784-792.2006	2006	*
Metabolism	Growth-promoting effects of lactoferrin on L. acidophilus and Bifidobacterium spp.	Kim WS, Ohashi M, Tanaka T, Kumura H, Kim GY, Kwon IK, Goh JS, Shimazaki K	Biometals	10.1023/b:biom.0000027705.57430.f1	2004	*
Metabolism	Cholic acid accumulation and its diminution by short-chain fatty acids in bifidobacteria.	Kurdi P, Tanaka H, van Veen HW, Asano K, Tomita F, Yokota A	Microbiology (Reading)	10.1099/mic.0.26376-0	2003	*
Metabolism	The effect of nisin on the physiology of Bifidobacterium thermophilum.	Kot E, Murad Y, Bezkorovainy A	J Food Prot	10.4315/0362-028x-64.8.1206	2001	*
Cultivation	Effects of fructooligosaccharides and their monomeric components on bile salt resistance in three species of bifidobacteria.	Perrin S, Grill JP, Schneider F	J Appl Microbiol	10.1046/j.1365-2672.2000.01070.x	2000	*
Metabolism	Involvement of trihydroxyconjugated bile salts in cholesterol assimilation by bifidobacteria.	Tahri K, Grill JP, Schneider F	Curr Microbiol	10.1007/s002849900148	1997	*
Pathogenicity	Effect of bifidogenic factors on growth characteristics of bifidobacteria in infant formulas.	Dubey UK, Mistry VV	J Dairy Sci	10.3168/jds.S0022-0302(96)76469-X	1996	*
Pathogenicity	Growth characteristics of bifidobacteria in infant formulas.	Dubey UK, Mistry VV	J Dairy Sci	10.3168/jds.S0022-0302(96)76468-8	1996	*
	Evaluation of Bifidobacteria and Lactobacillus Probiotics as Alternative Therapy for Salmonella typhimurium Infection in Broiler Chickens.	El-Sharkawy H, Tahoun A, Rizk AM, Suzuki T, Elmonir W, Nassef E, Shukry M, Germoush MO, Farrag F, Bin-Jumah M, Mahmoud AM	Animals (Basel)	10.3390/ani10061023	2020	*
	Effects of Linoleic Acid on Gut-Derived Bifidobacterium breve DSM 20213: A Transcriptomic Approach.	Senizza A, Callegari ML, Senizza B, Minuti A, Rocchetti G, Morelli L, Patrone V	Microorganisms	10.3390/microorganisms7120710	2019	*
	Supplementation with Lactobacillus plantarum WCFS1 Prevents Decline of Mucus Barrier in Colon of Accelerated Aging Ercc1(-/Delta7) Mice.	van Beek AA, Sovran B, Hugenholtz F, Meijer B, Hoogerland JA, Mihailova V, van der Ploeg C, Belzer C, Boekschoten MV, Hoeijmakers JH, Vermeij WP, de Vos P, Wells JM, Leenen PJ, Nicoletti C, Hendriks RW, Savelkoul HF	Front Immunol	10.3389/fimmu.2016.00408	2016	*
	A Novel Lactobacillus casei LP1 Producing 1,4-Dihydroxy-2-Naphthoic Acid, a Bifidogenic Growth Stimulator.	Kang JE, Kim TJ, Moon GS	Prev Nutr Food Sci	10.3746/pnf.2015.20.1.78	2015	*

References

#8482

Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 20213

#20215

Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 )

#20218

Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 )

#42088 ; Curators of the CIP;

#66792

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#66794

Antje Chang, Lisa Jeske, Sandra Ulbrich, Julia Hofmann, Julia Koblitz, Ida Schomburg, Meina Neumann-Schaal, Dieter Jahn, Dietmar Schomburg: BRENDA, the ELIXIR core data resource in 2021: new developments and updates. Nucleic Acids Res. 49: D498 - D508 2020 ( DOI 10.1093/nar/gkaa1025 , PubMed 33211880 )

#67770 Japan Collection of Microorganism (JCM) ; Curators of the JCM;

#68371

Automatically annotated from API 50CH acid .

#68382

Automatically annotated from API zym .

#69479

João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta .

#69480

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#69481

Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch: Predictions based on the model GenomeNet Sporulation v. 1 . ( DOI 10.21203/rs.3.rs-2527258/v1 )

#71342

Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.: StrainInfo: A central database for resolving microbial strain identifiers . ( DOI 10.60712/SI-ID92168.1 )

#117003 Collection of Institut Pasteur ; Curators of the CIP; CIP 64.69
* These data were automatically processed and therefore are not curated

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Search for species Bifidobacterium breve in external resources:
SILVA
BRENDA
PANGAEA
StrainInfo
GBIF

Bifidobacterium breve DSM 20213 = JCM 1192 JCM 1192

Bifidobacterium breve DSM 20213 = JCM 1192 JCM 1192

Change proposal

Change proposal